ilS presents the Second Edition of ilS Speaker Series(SM) focused this year on Rare Diseases
Although Rare Diseases are those that affect a small number of the population (5 out of 10,000 inhabitants), only in Spain there are more than 3 million people affected by this condition. For that reason ilS has decided to focus the Second Edition of its ilS Speaker SeriesSM on this subject with a presentation entitled: "Orphan Drugs: How to Speed Up their Access to Patients with rare diseases?”.
ilS will donate 30% of the money raised in the event to the Spanish Federation of Rare Diseases (FEDER), an organization that represents individuals suffering rare diseases and their families.
At the conference, which will take place on March 27th in Madrid (Spain) from 10:00h to 13:00h, ilS will count with different expert views on this subject, including: Mr. Justo Herranz, member of the Board and the Executive Committee of the Spanish Federation of Rare Diseases (FEDER), Dr. Antonio Blázquez, Head of Department of Medicines for Human Use (AEMPS), Mr. Julio Sánchez Fierro, VP of the Spanish Association of Healthcare Law and Ms. Concha Serrano, Coordinator of the Health Commission of ASEBIO.
ilS acts as a bridge between Life Sciences Experts and the Biopharmaceutical Industry and, as a result, the ilS Speaker SeriesSM will be represented by Industry Representatives, Medical Specialists, Pharmacists, Hospital Managers and Authorities at Regional and National Levels.
ilS Speaker Series℠ is fully committed to encourage debate and generate knowledge.
Picture: ilS Speaker SeriesSM last year Edition.